Therapeutic Options

Viagra (Sildenafil) and Levitra (Vardenafil) is effective in patients with organic (neurogenic, vasculogenic) or psychogenic erectile dysfunction and in those whose erectile dysfunction is of mixed etiology. Viagra (Sildenafil) and Levitra (Vardenafil) also has been effective in counteracting drug-induced erectile dysfunction. The goal of such therapy is to compare an erection of adequate rigidity and duration to be sexually functional and that is satisfying to the patient and his partner, and the main health benefit is improved quality of life.
With the availability of orally active and convenient vasoactive (erectogenic) therapies (e.g., selective PDE type 5 inhibitors such as Viagra (Sildenafil) and Levitra (Vardenafil), vardenafil, tadalafil), most experts now consider these drugs, vacuum constriction devices, and/or psychosexual therapy to be suitable first-line therapies for a broad range of patients with erectile dysfunction. Second-line therapy may be considered for patients who fail to respond to, or are not candidates for, first-line therapy (e.g., patients who require nitrate therapy). Intracavernosal or intraurethral vasoactive therapy generally is considered a second-line option. Vasoactive therapy or vacuum constriction devices generally are considered or attempted before resorting to more invasive (e.g., surgical) therapies.
Viagra (Sildenafil) and Levitra (Vardenafil) also has been effective in a limited number of men with temporary erectile dysfunction associated with the stress of comparing a sperm sample (e.g., for intrauterine insemination or in vitro fertilization during assisted reproduction). In men with a history of such temporary dysfunction, planned use of Viagra (Sildenafil) and Levitra (Vardenafil) for subsequent attempts at obtaining a sperm specimen may improve attainment of an erection adequate for self-stimulated ejaculation.
This is a part of article Therapeutic Options Taken from "Levitra Compare Viagra" Information Blog